New York - Session 2025-2026
Title: Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology
Provides for patient access to FDA approved abuse-deterrent technology to help combat opioid abuse.
Tracking state legislation? Support LegiList with a small contribution. Independent, ad-free, and built by one developer.
| Date | Event | Detail |
|---|---|---|
| 2025-03-27 | Introduced | Bill introduced |
| 2026-01-07 | Status | in_committee |
| 2026-01-07 | Latest Action | In Senate Committee |
| Bill | Title | Status |
|---|---|---|
| A 8820 | Authorizes the office of cannabis management and cannabis control board establish a track and trace program | in_committee |
| A 10060 | Authorizes high schools to include opioid overdose prevention and non-intravenous opioid antagonist administration as part of required health education courses | in_committee |
| A 10810 | Prohibits adult-use cannabis dispensaries from being located within a certain distance of the property boundary of a public school, public park, or beach | in_committee |
| A 9002 | Relates to exemptions from the recipient restriction program | in_committee |
| S 7984 | Relates to exemptions from the recipient restriction program | in_committee |
| S 8951 | Prohibits cannabis inversion | in_committee |
| S 9627 | Authorizes certain patients to use medical cannabis at certain health care facilities | in_committee |
| S 56 | Establishes a drug checking program | in_committee |